179 related articles for article (PubMed ID: 22922832)
21. TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling.
Ke X; Zhao Y; Lu X; Wang Z; Liu Y; Ren M; Lu G; Zhang D; Sun Z; Xu Z; Song JH; Cheng Y; Meltzer SJ; He S
Oncotarget; 2015 Oct; 6(32):32610-21. PubMed ID: 26416455
[TBL] [Abstract][Full Text] [Related]
22. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.
Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF
Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618
[TBL] [Abstract][Full Text] [Related]
23. RNA interference-mediated silencing of Stat5 induces apoptosis and growth suppression of hepatocellular carcinoma cells.
Zhang L; Zhao Z; Feng Z; Yin N; Lu G; Shan B
Neoplasma; 2012; 59(3):302-9. PubMed ID: 22296499
[TBL] [Abstract][Full Text] [Related]
24. Gamma-secretase complex-dependent intramembrane proteolysis of CD147 regulates the Notch1 signaling pathway in hepatocellular carcinoma.
Yong YL; Zhang RY; Liu ZK; Wei D; Shang YK; Wu J; Zhang ZY; Li C; Chen ZN; Bian H
J Pathol; 2019 Oct; 249(2):255-267. PubMed ID: 31215640
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of fractalkine inhibits the in vitro and in vivo angiogenesis of the hepatocellular carcinoma HepG2 cells.
Li F; Wang Z; Liu Y; Li J
Oncol Rep; 2010 Sep; 24(3):669-75. PubMed ID: 20664972
[TBL] [Abstract][Full Text] [Related]
26. [Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference].
Xu JY; Chen LB; Xu JY; Yang Z; Xu RH; Wei HY
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):481-4. PubMed ID: 16772086
[TBL] [Abstract][Full Text] [Related]
27. Activated Notch signaling is required for hepatitis B virus X protein to promote proliferation and survival of human hepatic cells.
Wang F; Zhou H; Xia X; Sun Q; Wang Y; Cheng B
Cancer Lett; 2010 Dec; 298(1):64-73. PubMed ID: 20638778
[TBL] [Abstract][Full Text] [Related]
28. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms.
Cantarini MC; de la Monte SM; Pang M; Tong M; D'Errico A; Trevisani F; Wands JR
Hepatology; 2006 Aug; 44(2):446-57. PubMed ID: 16871543
[TBL] [Abstract][Full Text] [Related]
29. Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells.
Jie X; Lang C; Jian Q; Chaoqun L; Dehua Y; Yi S; Yanping J; Luokun X; Qiuping Z; Hui W; Feili G; Boquan J; Youxin J; Jinquan T
Oncogene; 2007 Aug; 26(39):5741-51. PubMed ID: 17369855
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of MiR-93 expression reduces cell proliferation and clonogenicity of HepG2 cells.
Xu D; He XX; Chang Y; Sun SZ; Xu CR; Lin JS
Hepatogastroenterology; 2012; 59(120):2367-73. PubMed ID: 22773266
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma.
Sheng SL; Liu JJ; Dai YH; Sun XG; Xiong XP; Huang G
FEBS J; 2012 Oct; 279(20):3898-910. PubMed ID: 22897481
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of LAPTM4B-35 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo.
Yang H; Xiong F; Wei X; Yang Y; McNutt MA; Zhou R
Cancer Lett; 2010 Aug; 294(2):236-44. PubMed ID: 20202745
[TBL] [Abstract][Full Text] [Related]
33. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH
Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
[TBL] [Abstract][Full Text] [Related]
34. Bystin-like protein is upregulated in hepatocellular carcinoma and required for nucleologenesis in cancer cell proliferation.
Wang H; Xiao W; Zhou Q; Chen Y; Yang S; Sheng J; Yin Y; Fan J; Zhou J
Cell Res; 2009 Oct; 19(10):1150-64. PubMed ID: 19687802
[TBL] [Abstract][Full Text] [Related]
35. Hepassocin regulates cell proliferation of the human hepatic cells L02 and hepatocarcinoma cells through different mechanisms.
Cao MM; Xu WX; Li CY; Cao CZ; Wang ZD; Yao JW; Yu M; Zhan YQ; Wang XH; Tang LJ; Chen H; Li W; Ge CH; Yang XM
J Cell Biochem; 2011 Oct; 112(10):2882-90. PubMed ID: 21618590
[TBL] [Abstract][Full Text] [Related]
36. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression.
Liu ZJ; Xiao M; Balint K; Smalley KS; Brafford P; Qiu R; Pinnix CC; Li X; Herlyn M
Cancer Res; 2006 Apr; 66(8):4182-90. PubMed ID: 16618740
[TBL] [Abstract][Full Text] [Related]
37. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
38. Possible role of visfatin in hepatoma progression and the effects of branched-chain amino acids on visfatin-induced proliferation in human hepatoma cells.
Ninomiya S; Shimizu M; Imai K; Takai K; Shiraki M; Hara T; Tsurumi H; Ishizaki S; Moriwaki H
Cancer Prev Res (Phila); 2011 Dec; 4(12):2092-100. PubMed ID: 21952585
[TBL] [Abstract][Full Text] [Related]
39. Notch1-Snail1-E-cadherin pathway in metastatic hepatocellular carcinoma.
Wang XQ; Zhang W; Lui EL; Zhu Y; Lu P; Yu X; Sun J; Yang S; Poon RT; Fan ST
Int J Cancer; 2012 Aug; 131(3):E163-72. PubMed ID: 22052196
[TBL] [Abstract][Full Text] [Related]
40. [Melanoma differentiation associated gene-7 and interleukin-24 selectively induces growth arrest and apoptosis in hepatocellular carcinoma cell lines in vitro].
Wang CJ; Peng ZH; Yu Y; Chen K; Zheng JW; Hu HY; Ji WW; Xue XB
Zhonghua Wai Ke Za Zhi; 2007 Sep; 45(17):1202-5. PubMed ID: 18067718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
